nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—Pimecrolimus—atopic dermatitis	0.207	0.5	CrCtD
Temsirolimus—Tacrolimus—atopic dermatitis	0.207	0.5	CrCtD
Temsirolimus—MTOR—Pimecrolimus—atopic dermatitis	0.0764	0.291	CbGbCtD
Temsirolimus—FKBP1A—Pimecrolimus—atopic dermatitis	0.0661	0.251	CbGbCtD
Temsirolimus—MTOR—Tacrolimus—atopic dermatitis	0.0455	0.173	CbGbCtD
Temsirolimus—Everolimus—Pimecrolimus—atopic dermatitis	0.0447	0.167	CrCrCtD
Temsirolimus—Pimecrolimus—Tacrolimus—atopic dermatitis	0.0447	0.167	CrCrCtD
Temsirolimus—Everolimus—Tacrolimus—atopic dermatitis	0.0447	0.167	CrCrCtD
Temsirolimus—Sirolimus—Tacrolimus—atopic dermatitis	0.0447	0.167	CrCrCtD
Temsirolimus—Tacrolimus—Pimecrolimus—atopic dermatitis	0.0447	0.167	CrCrCtD
Temsirolimus—Sirolimus—Pimecrolimus—atopic dermatitis	0.0447	0.167	CrCrCtD
Temsirolimus—FKBP1A—Tacrolimus—atopic dermatitis	0.0393	0.149	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.00381	0.0145	CbGbCtD
Temsirolimus—CYP3A7—Tacrolimus—atopic dermatitis	0.00381	0.0145	CbGbCtD
Temsirolimus—CYP3A5—Tacrolimus—atopic dermatitis	0.00286	0.0109	CbGbCtD
Temsirolimus—CYP3A4—Pimecrolimus—atopic dermatitis	0.00187	0.00712	CbGbCtD
Temsirolimus—ABCB1—Tacrolimus—atopic dermatitis	0.00186	0.00707	CbGbCtD
Temsirolimus—CYP3A7—Hydrocortisone—atopic dermatitis	0.00155	0.00589	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00155	0.00589	CbGbCtD
Temsirolimus—ABCB1—Loratadine—atopic dermatitis	0.00136	0.00517	CbGbCtD
Temsirolimus—CYP2D6—Loratadine—atopic dermatitis	0.00128	0.00487	CbGbCtD
Temsirolimus—CYP2D6—Diphenhydramine—atopic dermatitis	0.00128	0.00487	CbGbCtD
Temsirolimus—ABCB1—Methylprednisolone—atopic dermatitis	0.00124	0.00473	CbGbCtD
Temsirolimus—CYP3A5—Hydrocortisone—atopic dermatitis	0.00116	0.00442	CbGbCtD
Temsirolimus—CYP3A4—Tacrolimus—atopic dermatitis	0.00111	0.00423	CbGbCtD
Temsirolimus—CYP3A7—Dexamethasone—atopic dermatitis	0.000964	0.00367	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.000964	0.00367	CbGbCtD
Temsirolimus—CYP3A4—Loratadine—atopic dermatitis	0.000815	0.0031	CbGbCtD
Temsirolimus—ABCB1—Betamethasone—atopic dermatitis	0.000809	0.00308	CbGbCtD
Temsirolimus—ABCB1—Prednisolone—atopic dermatitis	0.000798	0.00304	CbGbCtD
Temsirolimus—ABCB1—Hydrocortisone—atopic dermatitis	0.000757	0.00288	CbGbCtD
Temsirolimus—ABCB1—Prednisone—atopic dermatitis	0.000754	0.00287	CbGbCtD
Temsirolimus—CYP3A4—Methylprednisolone—atopic dermatitis	0.000745	0.00283	CbGbCtD
Temsirolimus—CYP3A5—Dexamethasone—atopic dermatitis	0.000723	0.00275	CbGbCtD
Temsirolimus—CYP3A4—Triamcinolone—atopic dermatitis	0.000565	0.00215	CbGbCtD
Temsirolimus—CYP3A4—Betamethasone—atopic dermatitis	0.000485	0.00184	CbGbCtD
Temsirolimus—CYP3A4—Prednisolone—atopic dermatitis	0.000478	0.00182	CbGbCtD
Temsirolimus—ABCB1—Dexamethasone—atopic dermatitis	0.000471	0.00179	CbGbCtD
Temsirolimus—CYP3A4—Hydrocortisone—atopic dermatitis	0.000453	0.00172	CbGbCtD
Temsirolimus—CYP3A4—Prednisone—atopic dermatitis	0.000452	0.00172	CbGbCtD
Temsirolimus—CYP2D6—Dexamethasone—atopic dermatitis	0.000443	0.00169	CbGbCtD
Temsirolimus—CYP3A4—Dexamethasone—atopic dermatitis	0.000282	0.00107	CbGbCtD
Temsirolimus—MTOR—IFN-gamma pathway—CASP1—atopic dermatitis	0.000115	0.0121	CbGpPWpGaD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IFNG—atopic dermatitis	0.000114	0.012	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—STAT6—atopic dermatitis	0.000113	0.0119	CbGpPWpGaD
Temsirolimus—MTOR—CXCR3-mediated signaling events—CXCL10—atopic dermatitis	0.000103	0.0108	CbGpPWpGaD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL2—atopic dermatitis	0.000102	0.0107	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—FCER1A—atopic dermatitis	8.7e-05	0.00914	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL5—atopic dermatitis	8.15e-05	0.00856	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MS4A2—atopic dermatitis	8.09e-05	0.00849	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—CXCL10—atopic dermatitis	7.38e-05	0.00775	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—IFNG—atopic dermatitis	6.96e-05	0.00731	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—BDNF—atopic dermatitis	6.63e-05	0.00696	CbGpPWpGaD
Temsirolimus—MTOR—Type II diabetes mellitus—MAPK8—atopic dermatitis	6.56e-05	0.00689	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—CMA1—atopic dermatitis	6.25e-05	0.00657	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—KIF3A—atopic dermatitis	6.25e-05	0.00656	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL4—atopic dermatitis	6.16e-05	0.00647	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL18—atopic dermatitis	6.14e-05	0.00645	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—CD8A—atopic dermatitis	6.05e-05	0.00635	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL10—atopic dermatitis	5.96e-05	0.00626	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL4—atopic dermatitis	5.95e-05	0.00625	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL4—atopic dermatitis	5.8e-05	0.00609	CbGpPWpGaD
Temsirolimus—MTOR—TSLP Signaling Pathway—NFKBIA—atopic dermatitis	5.7e-05	0.00599	CbGpPWpGaD
Temsirolimus—FKBP1A—Role of Calcineurin-dependent NFAT signaling in lymphocytes—MAPK8—atopic dermatitis	5.69e-05	0.00598	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—CCR5—atopic dermatitis	5.53e-05	0.00581	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—STAT6—atopic dermatitis	5.29e-05	0.00555	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CTSE—atopic dermatitis	5.25e-05	0.00552	CbGpPWpGaD
Temsirolimus—MTOR—Type II diabetes mellitus—TNF—atopic dermatitis	5.19e-05	0.00545	CbGpPWpGaD
Temsirolimus—MTOR—RANKL/RANK Signaling Pathway—NFKBIA—atopic dermatitis	5.03e-05	0.00528	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CABIN1—atopic dermatitis	5e-05	0.00525	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CARD11—atopic dermatitis	4.99e-05	0.00524	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—STAT6—atopic dermatitis	4.79e-05	0.00503	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CARD11—atopic dermatitis	4.77e-05	0.00501	CbGpPWpGaD
Temsirolimus—MTOR—IL2 signaling events mediated by PI3K—IL2—atopic dermatitis	4.71e-05	0.00494	CbGpPWpGaD
Temsirolimus—MTOR—IFN-gamma pathway—IFNG—atopic dermatitis	4.7e-05	0.00493	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.51e-05	0.00474	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—TNF—atopic dermatitis	4.5e-05	0.00473	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CARD11—atopic dermatitis	4.41e-05	0.00463	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—NFKBIA—atopic dermatitis	4.4e-05	0.00462	CbGpPWpGaD
Temsirolimus—MTOR—IFN-gamma pathway—IL1B—atopic dermatitis	4.19e-05	0.0044	CbGpPWpGaD
Temsirolimus—MTOR—TSLP Signaling Pathway—CXCL8—atopic dermatitis	4.07e-05	0.00427	CbGpPWpGaD
Temsirolimus—MTOR—ErbB2/ErbB3 signaling events—MAPK8—atopic dermatitis	3.99e-05	0.00419	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	3.95e-05	0.00415	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—NGF—atopic dermatitis	3.75e-05	0.00394	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IFNG—atopic dermatitis	3.72e-05	0.00391	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IFNG—atopic dermatitis	3.6e-05	0.00378	CbGpPWpGaD
Temsirolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	3.6e-05	0.00378	CbGpPWpGaD
Temsirolimus—MTOR—TSLP Signaling Pathway—MAPK8—atopic dermatitis	3.58e-05	0.00376	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—CD4—atopic dermatitis	3.47e-05	0.00365	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—CXCL8—atopic dermatitis	3.46e-05	0.00363	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FCER1A—atopic dermatitis	3.38e-05	0.00355	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL13—atopic dermatitis	3.38e-05	0.00355	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL1B—atopic dermatitis	3.32e-05	0.00349	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL2—atopic dermatitis	3.31e-05	0.00347	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.3e-05	0.00347	CbGpPWpGaD
Temsirolimus—MTOR—Wnt Signaling Pathway Netpath—MAPK8—atopic dermatitis	3.3e-05	0.00346	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—IFNG—atopic dermatitis	3.25e-05	0.00342	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL1B—atopic dermatitis	3.21e-05	0.00337	CbGpPWpGaD
Temsirolimus—MTOR—ErbB Signaling Pathway—MAPK8—atopic dermatitis	3.2e-05	0.00336	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL2—atopic dermatitis	3.2e-05	0.00336	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTSE—atopic dermatitis	3.19e-05	0.00335	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—BDNF—atopic dermatitis	3.18e-05	0.00334	CbGpPWpGaD
Temsirolimus—MTOR—RANKL/RANK Signaling Pathway—MAPK8—atopic dermatitis	3.15e-05	0.00331	CbGpPWpGaD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—MAPK8—atopic dermatitis	3.15e-05	0.00331	CbGpPWpGaD
Temsirolimus—MTOR—Costimulation by the CD28 family—CD4—atopic dermatitis	3.14e-05	0.0033	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MS4A2—atopic dermatitis	3.14e-05	0.0033	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	3.11e-05	0.00326	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.98e-05	0.00313	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CD79A—atopic dermatitis	2.92e-05	0.00307	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—IL2—atopic dermatitis	2.89e-05	0.00304	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL5—atopic dermatitis	2.89e-05	0.00303	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—NGF—atopic dermatitis	2.82e-05	0.00296	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—DEFB1—atopic dermatitis	2.8e-05	0.00294	CbGpPWpGaD
Temsirolimus—Hyperglycaemia—Betamethasone—atopic dermatitis	2.79e-05	0.000628	CcSEcCtD
Temsirolimus—Hyperglycaemia—Dexamethasone—atopic dermatitis	2.79e-05	0.000628	CcSEcCtD
Temsirolimus—Vomiting—Fluocinolone Acetonide—atopic dermatitis	2.77e-05	0.000621	CcSEcCtD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—MAPK8—atopic dermatitis	2.76e-05	0.0029	CbGpPWpGaD
Temsirolimus—Alanine aminotransferase increased—Prednisone—atopic dermatitis	2.75e-05	0.000619	CcSEcCtD
Temsirolimus—Rash—Fluocinolone Acetonide—atopic dermatitis	2.74e-05	0.000616	CcSEcCtD
Temsirolimus—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	2.74e-05	0.000616	CcSEcCtD
Temsirolimus—Rhinitis—Triamcinolone—atopic dermatitis	2.74e-05	0.000616	CcSEcCtD
Temsirolimus—Rhinitis—Methylprednisolone—atopic dermatitis	2.73e-05	0.000614	CcSEcCtD
Temsirolimus—Headache—Fluocinolone Acetonide—atopic dermatitis	2.72e-05	0.000612	CcSEcCtD
Temsirolimus—Abdominal distension—Prednisone—atopic dermatitis	2.72e-05	0.00061	CcSEcCtD
Temsirolimus—Pharyngitis—Triamcinolone—atopic dermatitis	2.71e-05	0.000609	CcSEcCtD
Temsirolimus—Eye disorder—Hydrocortisone—atopic dermatitis	2.71e-05	0.000609	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Tacrolimus—atopic dermatitis	2.7e-05	0.000607	CcSEcCtD
Temsirolimus—Conjunctivitis—Dexamethasone—atopic dermatitis	2.69e-05	0.000603	CcSEcCtD
Temsirolimus—Conjunctivitis—Betamethasone—atopic dermatitis	2.69e-05	0.000603	CcSEcCtD
Temsirolimus—MTOR—Leptin signaling pathway—IL1B—atopic dermatitis	2.68e-05	0.00282	CbGpPWpGaD
Temsirolimus—Connective tissue disorder—Methylprednisolone—atopic dermatitis	2.68e-05	0.000602	CcSEcCtD
Temsirolimus—MTOR—CXCR4-mediated signaling events—CD4—atopic dermatitis	2.65e-05	0.00279	CbGpPWpGaD
Temsirolimus—Vomiting—Mometasone—atopic dermatitis	2.64e-05	0.000593	CcSEcCtD
Temsirolimus—Immune system disorder—Hydrocortisone—atopic dermatitis	2.62e-05	0.000589	CcSEcCtD
Temsirolimus—Rash—Mometasone—atopic dermatitis	2.62e-05	0.000588	CcSEcCtD
Temsirolimus—Dermatitis—Mometasone—atopic dermatitis	2.62e-05	0.000588	CcSEcCtD
Temsirolimus—Abdominal pain—Tacrolimus—atopic dermatitis	2.61e-05	0.000587	CcSEcCtD
Temsirolimus—Body temperature increased—Tacrolimus—atopic dermatitis	2.61e-05	0.000587	CcSEcCtD
Temsirolimus—Headache—Mometasone—atopic dermatitis	2.6e-05	0.000585	CcSEcCtD
Temsirolimus—MTOR—CDC42 signaling events—MAPK8—atopic dermatitis	2.6e-05	0.00273	CbGpPWpGaD
Temsirolimus—Erythema—Prednisolone—atopic dermatitis	2.59e-05	0.000581	CcSEcCtD
Temsirolimus—Nausea—Fluocinolone Acetonide—atopic dermatitis	2.58e-05	0.00058	CcSEcCtD
Temsirolimus—FKBP1A—Disease—GLB1—atopic dermatitis	2.56e-05	0.00268	CbGpPWpGaD
Temsirolimus—Eye disorder—Methylprednisolone—atopic dermatitis	2.55e-05	0.000573	CcSEcCtD
Temsirolimus—Mental disorder—Hydrocortisone—atopic dermatitis	2.54e-05	0.000571	CcSEcCtD
Temsirolimus—Cardiac disorder—Methylprednisolone—atopic dermatitis	2.53e-05	0.000569	CcSEcCtD
Temsirolimus—Malnutrition—Hydrocortisone—atopic dermatitis	2.53e-05	0.000568	CcSEcCtD
Temsirolimus—Erythema—Hydrocortisone—atopic dermatitis	2.53e-05	0.000568	CcSEcCtD
Temsirolimus—Neutropenia—Prednisone—atopic dermatitis	2.52e-05	0.000567	CcSEcCtD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—TNF—atopic dermatitis	2.5e-05	0.00262	CbGpPWpGaD
Temsirolimus—Angiopathy—Methylprednisolone—atopic dermatitis	2.47e-05	0.000556	CcSEcCtD
Temsirolimus—Nausea—Mometasone—atopic dermatitis	2.47e-05	0.000554	CcSEcCtD
Temsirolimus—Immune system disorder—Methylprednisolone—atopic dermatitis	2.46e-05	0.000553	CcSEcCtD
Temsirolimus—MTOR—Leptin signaling pathway—MAPK8—atopic dermatitis	2.46e-05	0.00258	CbGpPWpGaD
Temsirolimus—Mediastinal disorder—Methylprednisolone—atopic dermatitis	2.46e-05	0.000552	CcSEcCtD
Temsirolimus—Weight decreased—Prednisone—atopic dermatitis	2.44e-05	0.000548	CcSEcCtD
Temsirolimus—Hypersensitivity—Tacrolimus—atopic dermatitis	2.44e-05	0.000547	CcSEcCtD
Temsirolimus—Hyperglycaemia—Prednisone—atopic dermatitis	2.43e-05	0.000547	CcSEcCtD
Temsirolimus—FKBP1A—Spinal Cord Injury—TNF—atopic dermatitis	2.41e-05	0.00253	CbGpPWpGaD
Temsirolimus—Depression—Prednisone—atopic dermatitis	2.4e-05	0.000539	CcSEcCtD
Temsirolimus—Mental disorder—Methylprednisolone—atopic dermatitis	2.39e-05	0.000537	CcSEcCtD
Temsirolimus—Erythema—Triamcinolone—atopic dermatitis	2.38e-05	0.000534	CcSEcCtD
Temsirolimus—Erythema—Methylprednisolone—atopic dermatitis	2.37e-05	0.000533	CcSEcCtD
Temsirolimus—Malnutrition—Methylprednisolone—atopic dermatitis	2.37e-05	0.000533	CcSEcCtD
Temsirolimus—Asthenia—Tacrolimus—atopic dermatitis	2.37e-05	0.000533	CcSEcCtD
Temsirolimus—Angioedema—Prednisolone—atopic dermatitis	2.36e-05	0.000531	CcSEcCtD
Temsirolimus—Pruritus—Tacrolimus—atopic dermatitis	2.34e-05	0.000525	CcSEcCtD
Temsirolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MAPK8—atopic dermatitis	2.34e-05	0.00245	CbGpPWpGaD
Temsirolimus—Dysgeusia—Triamcinolone—atopic dermatitis	2.33e-05	0.000523	CcSEcCtD
Temsirolimus—MTOR—BDNF signaling pathway—NFKBIA—atopic dermatitis	2.33e-05	0.00244	CbGpPWpGaD
Temsirolimus—Eye disorder—Betamethasone—atopic dermatitis	2.32e-05	0.000521	CcSEcCtD
Temsirolimus—Eye disorder—Dexamethasone—atopic dermatitis	2.32e-05	0.000521	CcSEcCtD
Temsirolimus—Angioedema—Hydrocortisone—atopic dermatitis	2.31e-05	0.000519	CcSEcCtD
Temsirolimus—Back pain—Triamcinolone—atopic dermatitis	2.3e-05	0.000517	CcSEcCtD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IFNG—atopic dermatitis	2.3e-05	0.00241	CbGpPWpGaD
Temsirolimus—MTOR—TSLP Signaling Pathway—IL6—atopic dermatitis	2.28e-05	0.0024	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FCER2—atopic dermatitis	2.26e-05	0.00238	CbGpPWpGaD
Temsirolimus—Diarrhoea—Tacrolimus—atopic dermatitis	2.26e-05	0.000508	CcSEcCtD
Temsirolimus—Angiopathy—Betamethasone—atopic dermatitis	2.25e-05	0.000505	CcSEcCtD
Temsirolimus—Angiopathy—Dexamethasone—atopic dermatitis	2.25e-05	0.000505	CcSEcCtD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—atopic dermatitis	2.25e-05	0.00236	CbGpPWpGaD
Temsirolimus—Convulsion—Prednisolone—atopic dermatitis	2.24e-05	0.000504	CcSEcCtD
Temsirolimus—Hypertension—Prednisolone—atopic dermatitis	2.23e-05	0.000502	CcSEcCtD
Temsirolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.22e-05	0.00233	CbGpPWpGaD
Temsirolimus—Convulsion—Hydrocortisone—atopic dermatitis	2.19e-05	0.000492	CcSEcCtD
Temsirolimus—Dizziness—Tacrolimus—atopic dermatitis	2.19e-05	0.000491	CcSEcCtD
Temsirolimus—Hypertension—Hydrocortisone—atopic dermatitis	2.18e-05	0.00049	CcSEcCtD
Temsirolimus—Angioedema—Triamcinolone—atopic dermatitis	2.17e-05	0.000488	CcSEcCtD
Temsirolimus—Angioedema—Methylprednisolone—atopic dermatitis	2.17e-05	0.000487	CcSEcCtD
Temsirolimus—Erythema—Dexamethasone—atopic dermatitis	2.16e-05	0.000485	CcSEcCtD
Temsirolimus—Erythema—Betamethasone—atopic dermatitis	2.16e-05	0.000485	CcSEcCtD
Temsirolimus—Myalgia—Hydrocortisone—atopic dermatitis	2.15e-05	0.000483	CcSEcCtD
Temsirolimus—MTOR—Adaptive Immune System—KIF3A—atopic dermatitis	2.15e-05	0.00226	CbGpPWpGaD
Temsirolimus—Anxiety—Hydrocortisone—atopic dermatitis	2.14e-05	0.000482	CcSEcCtD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—atopic dermatitis	2.14e-05	0.00224	CbGpPWpGaD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	2.14e-05	0.00048	CcSEcCtD
Temsirolimus—Connective tissue disorder—Prednisone—atopic dermatitis	2.12e-05	0.000477	CcSEcCtD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—NGF—atopic dermatitis	2.12e-05	0.00223	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL10—atopic dermatitis	2.11e-05	0.00222	CbGpPWpGaD
Temsirolimus—Oedema—Prednisolone—atopic dermatitis	2.11e-05	0.000474	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisolone—atopic dermatitis	2.11e-05	0.000474	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—CCL22—atopic dermatitis	2.1e-05	0.00221	CbGpPWpGaD
Temsirolimus—Vomiting—Tacrolimus—atopic dermatitis	2.1e-05	0.000472	CcSEcCtD
Temsirolimus—Rash—Tacrolimus—atopic dermatitis	2.08e-05	0.000468	CcSEcCtD
Temsirolimus—Dermatitis—Tacrolimus—atopic dermatitis	2.08e-05	0.000468	CcSEcCtD
Temsirolimus—Cough—Triamcinolone—atopic dermatitis	2.08e-05	0.000466	CcSEcCtD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.07e-05	0.00218	CbGpPWpGaD
Temsirolimus—Headache—Tacrolimus—atopic dermatitis	2.07e-05	0.000465	CcSEcCtD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKBIA—atopic dermatitis	2.07e-05	0.00217	CbGpPWpGaD
Temsirolimus—Oedema—Hydrocortisone—atopic dermatitis	2.06e-05	0.000463	CcSEcCtD
Temsirolimus—Anaphylactic shock—Hydrocortisone—atopic dermatitis	2.06e-05	0.000463	CcSEcCtD
Temsirolimus—Convulsion—Triamcinolone—atopic dermatitis	2.06e-05	0.000463	CcSEcCtD
Temsirolimus—Convulsion—Methylprednisolone—atopic dermatitis	2.06e-05	0.000462	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—IL4—atopic dermatitis	2.06e-05	0.00216	CbGpPWpGaD
Temsirolimus—Hypertension—Triamcinolone—atopic dermatitis	2.05e-05	0.000461	CcSEcCtD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—atopic dermatitis	2.05e-05	0.00215	CbGpPWpGaD
Temsirolimus—Hypertension—Methylprednisolone—atopic dermatitis	2.05e-05	0.00046	CcSEcCtD
Temsirolimus—Infection—Hydrocortisone—atopic dermatitis	2.05e-05	0.00046	CcSEcCtD
Temsirolimus—Myalgia—Triamcinolone—atopic dermatitis	2.03e-05	0.000455	CcSEcCtD
Temsirolimus—Nervous system disorder—Hydrocortisone—atopic dermatitis	2.02e-05	0.000454	CcSEcCtD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	2.02e-05	0.00212	CbGpPWpGaD
Temsirolimus—Arthralgia—Methylprednisolone—atopic dermatitis	2.02e-05	0.000454	CcSEcCtD
Temsirolimus—Myalgia—Methylprednisolone—atopic dermatitis	2.02e-05	0.000454	CcSEcCtD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	2.02e-05	0.00212	CbGpPWpGaD
Temsirolimus—Eye disorder—Prednisone—atopic dermatitis	2.02e-05	0.000453	CcSEcCtD
Temsirolimus—Anxiety—Methylprednisolone—atopic dermatitis	2.01e-05	0.000452	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	2.01e-05	0.000451	CcSEcCtD
Temsirolimus—Skin disorder—Hydrocortisone—atopic dermatitis	2e-05	0.00045	CcSEcCtD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKBIA—atopic dermatitis	1.97e-05	0.00207	CbGpPWpGaD
Temsirolimus—Angioedema—Dexamethasone—atopic dermatitis	1.97e-05	0.000443	CcSEcCtD
Temsirolimus—Angioedema—Betamethasone—atopic dermatitis	1.97e-05	0.000443	CcSEcCtD
Temsirolimus—MTOR—Immune System—FCER1A—atopic dermatitis	1.97e-05	0.00207	CbGpPWpGaD
Temsirolimus—Anorexia—Hydrocortisone—atopic dermatitis	1.97e-05	0.000442	CcSEcCtD
Temsirolimus—Nausea—Tacrolimus—atopic dermatitis	1.96e-05	0.000441	CcSEcCtD
Temsirolimus—Angiopathy—Prednisone—atopic dermatitis	1.96e-05	0.00044	CcSEcCtD
Temsirolimus—Immune system disorder—Prednisone—atopic dermatitis	1.95e-05	0.000438	CcSEcCtD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL6—atopic dermatitis	1.94e-05	0.00204	CbGpPWpGaD
Temsirolimus—Oedema—Triamcinolone—atopic dermatitis	1.94e-05	0.000436	CcSEcCtD
Temsirolimus—Anaphylactic shock—Triamcinolone—atopic dermatitis	1.94e-05	0.000436	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methylprednisolone—atopic dermatitis	1.94e-05	0.000435	CcSEcCtD
Temsirolimus—Infection—Triamcinolone—atopic dermatitis	1.93e-05	0.000433	CcSEcCtD
Temsirolimus—Infection—Methylprednisolone—atopic dermatitis	1.92e-05	0.000432	CcSEcCtD
Temsirolimus—Insomnia—Prednisolone—atopic dermatitis	1.91e-05	0.000429	CcSEcCtD
Temsirolimus—MTOR—Innate Immune System—STAT6—atopic dermatitis	1.9e-05	0.002	CbGpPWpGaD
Temsirolimus—Nervous system disorder—Methylprednisolone—atopic dermatitis	1.9e-05	0.000427	CcSEcCtD
Temsirolimus—Mental disorder—Prednisone—atopic dermatitis	1.89e-05	0.000425	CcSEcCtD
Temsirolimus—Skin disorder—Methylprednisolone—atopic dermatitis	1.88e-05	0.000423	CcSEcCtD
Temsirolimus—MTOR—ErbB1 downstream signaling—MAPK8—atopic dermatitis	1.88e-05	0.00197	CbGpPWpGaD
Temsirolimus—Malnutrition—Prednisone—atopic dermatitis	1.88e-05	0.000422	CcSEcCtD
Temsirolimus—Erythema—Prednisone—atopic dermatitis	1.88e-05	0.000422	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	1.88e-05	0.000422	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—CCL27—atopic dermatitis	1.88e-05	0.00197	CbGpPWpGaD
Temsirolimus—Convulsion—Dexamethasone—atopic dermatitis	1.87e-05	0.00042	CcSEcCtD
Temsirolimus—Convulsion—Betamethasone—atopic dermatitis	1.87e-05	0.00042	CcSEcCtD
Temsirolimus—Insomnia—Hydrocortisone—atopic dermatitis	1.87e-05	0.000419	CcSEcCtD
Temsirolimus—Hypertension—Dexamethasone—atopic dermatitis	1.86e-05	0.000419	CcSEcCtD
Temsirolimus—Hypertension—Betamethasone—atopic dermatitis	1.86e-05	0.000419	CcSEcCtD
Temsirolimus—MTOR—Innate Immune System—CARD11—atopic dermatitis	1.85e-05	0.00194	CbGpPWpGaD
Temsirolimus—Myalgia—Dexamethasone—atopic dermatitis	1.84e-05	0.000413	CcSEcCtD
Temsirolimus—Myalgia—Betamethasone—atopic dermatitis	1.84e-05	0.000413	CcSEcCtD
Temsirolimus—Anxiety—Betamethasone—atopic dermatitis	1.83e-05	0.000411	CcSEcCtD
Temsirolimus—Anxiety—Dexamethasone—atopic dermatitis	1.83e-05	0.000411	CcSEcCtD
Temsirolimus—MTOR—Immune System—MS4A2—atopic dermatitis	1.83e-05	0.00192	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—NFKBIA—atopic dermatitis	1.83e-05	0.00192	CbGpPWpGaD
Temsirolimus—Pain—Prednisolone—atopic dermatitis	1.81e-05	0.000406	CcSEcCtD
Temsirolimus—Decreased appetite—Hydrocortisone—atopic dermatitis	1.79e-05	0.000403	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	1.78e-05	0.0004	CcSEcCtD
Temsirolimus—MTOR—Adaptive Immune System—CARD11—atopic dermatitis	1.78e-05	0.00187	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—atopic dermatitis	1.78e-05	0.00187	CbGpPWpGaD
Temsirolimus—Fatigue—Hydrocortisone—atopic dermatitis	1.78e-05	0.000399	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	1.77e-05	0.000397	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	1.77e-05	0.000397	CcSEcCtD
Temsirolimus—Pain—Hydrocortisone—atopic dermatitis	1.76e-05	0.000396	CcSEcCtD
Temsirolimus—Anaphylactic shock—Dexamethasone—atopic dermatitis	1.76e-05	0.000396	CcSEcCtD
Temsirolimus—Anaphylactic shock—Betamethasone—atopic dermatitis	1.76e-05	0.000396	CcSEcCtD
Temsirolimus—Oedema—Betamethasone—atopic dermatitis	1.76e-05	0.000396	CcSEcCtD
Temsirolimus—Oedema—Dexamethasone—atopic dermatitis	1.76e-05	0.000396	CcSEcCtD
Temsirolimus—Insomnia—Triamcinolone—atopic dermatitis	1.76e-05	0.000395	CcSEcCtD
Temsirolimus—Insomnia—Methylprednisolone—atopic dermatitis	1.75e-05	0.000394	CcSEcCtD
Temsirolimus—Infection—Dexamethasone—atopic dermatitis	1.75e-05	0.000393	CcSEcCtD
Temsirolimus—Infection—Betamethasone—atopic dermatitis	1.75e-05	0.000393	CcSEcCtD
Temsirolimus—Anaemia—Prednisone—atopic dermatitis	1.74e-05	0.00039	CcSEcCtD
Temsirolimus—Dyspnoea—Triamcinolone—atopic dermatitis	1.73e-05	0.000389	CcSEcCtD
Temsirolimus—Nervous system disorder—Betamethasone—atopic dermatitis	1.73e-05	0.000388	CcSEcCtD
Temsirolimus—Nervous system disorder—Dexamethasone—atopic dermatitis	1.73e-05	0.000388	CcSEcCtD
Temsirolimus—Thrombocytopenia—Betamethasone—atopic dermatitis	1.73e-05	0.000388	CcSEcCtD
Temsirolimus—Thrombocytopenia—Dexamethasone—atopic dermatitis	1.73e-05	0.000388	CcSEcCtD
Temsirolimus—Angioedema—Prednisone—atopic dermatitis	1.72e-05	0.000386	CcSEcCtD
Temsirolimus—FKBP1A—Disease—SLC11A1—atopic dermatitis	1.71e-05	0.0018	CbGpPWpGaD
Temsirolimus—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	1.69e-05	0.000379	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—CCL17—atopic dermatitis	1.68e-05	0.00177	CbGpPWpGaD
Temsirolimus—Anorexia—Betamethasone—atopic dermatitis	1.68e-05	0.000377	CcSEcCtD
Temsirolimus—Anorexia—Dexamethasone—atopic dermatitis	1.68e-05	0.000377	CcSEcCtD
Temsirolimus—Fatigue—Triamcinolone—atopic dermatitis	1.67e-05	0.000376	CcSEcCtD
Temsirolimus—Fatigue—Methylprednisolone—atopic dermatitis	1.67e-05	0.000375	CcSEcCtD
Temsirolimus—Pain—Triamcinolone—atopic dermatitis	1.66e-05	0.000373	CcSEcCtD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.64e-05	0.00172	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—DEFB1—atopic dermatitis	1.63e-05	0.00171	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—NGF—atopic dermatitis	1.63e-05	0.00171	CbGpPWpGaD
Temsirolimus—Abdominal pain—Hydrocortisone—atopic dermatitis	1.63e-05	0.000366	CcSEcCtD
Temsirolimus—Body temperature increased—Hydrocortisone—atopic dermatitis	1.63e-05	0.000366	CcSEcCtD
Temsirolimus—Convulsion—Prednisone—atopic dermatitis	1.63e-05	0.000366	CcSEcCtD
Temsirolimus—Hypertension—Prednisone—atopic dermatitis	1.62e-05	0.000365	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	1.61e-05	0.000361	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	1.61e-05	0.000361	CcSEcCtD
Temsirolimus—Myalgia—Prednisone—atopic dermatitis	1.6e-05	0.00036	CcSEcCtD
Temsirolimus—Arthralgia—Prednisone—atopic dermatitis	1.6e-05	0.00036	CcSEcCtD
Temsirolimus—Anxiety—Prednisone—atopic dermatitis	1.6e-05	0.000358	CcSEcCtD
Temsirolimus—Insomnia—Dexamethasone—atopic dermatitis	1.59e-05	0.000358	CcSEcCtD
Temsirolimus—Insomnia—Betamethasone—atopic dermatitis	1.59e-05	0.000358	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	1.59e-05	0.000357	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	1.58e-05	0.000356	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisolone—atopic dermatitis	1.56e-05	0.000349	CcSEcCtD
Temsirolimus—Body temperature increased—Triamcinolone—atopic dermatitis	1.54e-05	0.000345	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisone—atopic dermatitis	1.53e-05	0.000345	CcSEcCtD
Temsirolimus—Oedema—Prednisone—atopic dermatitis	1.53e-05	0.000345	CcSEcCtD
Temsirolimus—Abdominal pain—Methylprednisolone—atopic dermatitis	1.53e-05	0.000344	CcSEcCtD
Temsirolimus—Decreased appetite—Betamethasone—atopic dermatitis	1.53e-05	0.000344	CcSEcCtD
Temsirolimus—Decreased appetite—Dexamethasone—atopic dermatitis	1.53e-05	0.000344	CcSEcCtD
Temsirolimus—Infection—Prednisone—atopic dermatitis	1.52e-05	0.000342	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Betamethasone—atopic dermatitis	1.52e-05	0.000342	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	1.52e-05	0.000342	CcSEcCtD
Temsirolimus—Hypersensitivity—Hydrocortisone—atopic dermatitis	1.52e-05	0.000341	CcSEcCtD
Temsirolimus—Fatigue—Betamethasone—atopic dermatitis	1.52e-05	0.000341	CcSEcCtD
Temsirolimus—Fatigue—Dexamethasone—atopic dermatitis	1.52e-05	0.000341	CcSEcCtD
Temsirolimus—Pain—Dexamethasone—atopic dermatitis	1.51e-05	0.000338	CcSEcCtD
Temsirolimus—Pain—Betamethasone—atopic dermatitis	1.51e-05	0.000338	CcSEcCtD
Temsirolimus—Nervous system disorder—Prednisone—atopic dermatitis	1.5e-05	0.000338	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—KIF3A—atopic dermatitis	1.5e-05	0.00157	CbGpPWpGaD
Temsirolimus—Skin disorder—Prednisone—atopic dermatitis	1.49e-05	0.000335	CcSEcCtD
Temsirolimus—Asthenia—Hydrocortisone—atopic dermatitis	1.48e-05	0.000332	CcSEcCtD
Temsirolimus—Anorexia—Prednisone—atopic dermatitis	1.46e-05	0.000329	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	1.46e-05	0.00153	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—MAPK8—atopic dermatitis	1.46e-05	0.00153	CbGpPWpGaD
Temsirolimus—Pruritus—Hydrocortisone—atopic dermatitis	1.46e-05	0.000328	CcSEcCtD
Temsirolimus—MTOR—Innate Immune System—CASP1—atopic dermatitis	1.44e-05	0.00152	CbGpPWpGaD
Temsirolimus—Gastrointestinal pain—Dexamethasone—atopic dermatitis	1.44e-05	0.000324	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Betamethasone—atopic dermatitis	1.44e-05	0.000324	CcSEcCtD
Temsirolimus—MTOR—Disease—GLB1—atopic dermatitis	1.44e-05	0.00151	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Triamcinolone—atopic dermatitis	1.43e-05	0.000321	CcSEcCtD
Temsirolimus—Hypersensitivity—Methylprednisolone—atopic dermatitis	1.43e-05	0.000321	CcSEcCtD
Temsirolimus—MTOR—IRS-mediated signalling—IL6—atopic dermatitis	1.42e-05	0.00149	CbGpPWpGaD
Temsirolimus—Diarrhoea—Hydrocortisone—atopic dermatitis	1.41e-05	0.000317	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Prednisone—atopic dermatitis	1.4e-05	0.000314	CcSEcCtD
Temsirolimus—Dizziness—Prednisolone—atopic dermatitis	1.4e-05	0.000314	CcSEcCtD
Temsirolimus—Asthenia—Triamcinolone—atopic dermatitis	1.39e-05	0.000313	CcSEcCtD
Temsirolimus—Abdominal pain—Betamethasone—atopic dermatitis	1.39e-05	0.000313	CcSEcCtD
Temsirolimus—Abdominal pain—Dexamethasone—atopic dermatitis	1.39e-05	0.000313	CcSEcCtD
Temsirolimus—Body temperature increased—Dexamethasone—atopic dermatitis	1.39e-05	0.000313	CcSEcCtD
Temsirolimus—Body temperature increased—Betamethasone—atopic dermatitis	1.39e-05	0.000313	CcSEcCtD
Temsirolimus—Asthenia—Methylprednisolone—atopic dermatitis	1.39e-05	0.000312	CcSEcCtD
Temsirolimus—Insomnia—Prednisone—atopic dermatitis	1.39e-05	0.000312	CcSEcCtD
Temsirolimus—MTOR—IRS-related events—IL6—atopic dermatitis	1.38e-05	0.00145	CbGpPWpGaD
Temsirolimus—Pruritus—Triamcinolone—atopic dermatitis	1.37e-05	0.000309	CcSEcCtD
Temsirolimus—Pruritus—Methylprednisolone—atopic dermatitis	1.37e-05	0.000308	CcSEcCtD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—atopic dermatitis	1.37e-05	0.00144	CbGpPWpGaD
Temsirolimus—Dizziness—Hydrocortisone—atopic dermatitis	1.36e-05	0.000306	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—CCL11—atopic dermatitis	1.36e-05	0.00142	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CMA1—atopic dermatitis	1.36e-05	0.00142	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—NFKBIA—atopic dermatitis	1.34e-05	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—MAPK8—atopic dermatitis	1.34e-05	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—IL6—atopic dermatitis	1.33e-05	0.0014	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—IL6—atopic dermatitis	1.33e-05	0.0014	CbGpPWpGaD
Temsirolimus—Decreased appetite—Prednisone—atopic dermatitis	1.33e-05	0.0003	CcSEcCtD
Temsirolimus—Rash—Prednisolone—atopic dermatitis	1.33e-05	0.000299	CcSEcCtD
Temsirolimus—Dermatitis—Prednisolone—atopic dermatitis	1.33e-05	0.000299	CcSEcCtD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	1.33e-05	0.0014	CbGpPWpGaD
Temsirolimus—Diarrhoea—Methylprednisolone—atopic dermatitis	1.33e-05	0.000298	CcSEcCtD
Temsirolimus—Fatigue—Prednisone—atopic dermatitis	1.32e-05	0.000297	CcSEcCtD
Temsirolimus—Headache—Prednisolone—atopic dermatitis	1.32e-05	0.000297	CcSEcCtD
Temsirolimus—Constipation—Prednisone—atopic dermatitis	1.31e-05	0.000295	CcSEcCtD
Temsirolimus—Vomiting—Hydrocortisone—atopic dermatitis	1.31e-05	0.000295	CcSEcCtD
Temsirolimus—MTOR—Innate Immune System—TLR2—atopic dermatitis	1.31e-05	0.00137	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—KIF3A—atopic dermatitis	1.3e-05	0.00137	CbGpPWpGaD
Temsirolimus—Rash—Hydrocortisone—atopic dermatitis	1.3e-05	0.000292	CcSEcCtD
Temsirolimus—Dermatitis—Hydrocortisone—atopic dermatitis	1.3e-05	0.000292	CcSEcCtD
Temsirolimus—Headache—Hydrocortisone—atopic dermatitis	1.29e-05	0.00029	CcSEcCtD
Temsirolimus—Dizziness—Triamcinolone—atopic dermatitis	1.28e-05	0.000288	CcSEcCtD
Temsirolimus—Dizziness—Methylprednisolone—atopic dermatitis	1.28e-05	0.000288	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—STAT6—atopic dermatitis	1.27e-05	0.00134	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FCER2—atopic dermatitis	1.27e-05	0.00134	CbGpPWpGaD
Temsirolimus—Asthenia—Betamethasone—atopic dermatitis	1.26e-05	0.000284	CcSEcCtD
Temsirolimus—Asthenia—Dexamethasone—atopic dermatitis	1.26e-05	0.000284	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Prednisone—atopic dermatitis	1.25e-05	0.000282	CcSEcCtD
Temsirolimus—Nausea—Prednisolone—atopic dermatitis	1.25e-05	0.000282	CcSEcCtD
Temsirolimus—Pruritus—Betamethasone—atopic dermatitis	1.25e-05	0.00028	CcSEcCtD
Temsirolimus—Pruritus—Dexamethasone—atopic dermatitis	1.25e-05	0.00028	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	1.24e-05	0.0013	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	1.24e-05	0.0013	CbGpPWpGaD
Temsirolimus—Vomiting—Triamcinolone—atopic dermatitis	1.23e-05	0.000277	CcSEcCtD
Temsirolimus—Vomiting—Methylprednisolone—atopic dermatitis	1.23e-05	0.000277	CcSEcCtD
Temsirolimus—Nausea—Hydrocortisone—atopic dermatitis	1.22e-05	0.000275	CcSEcCtD
Temsirolimus—Rash—Triamcinolone—atopic dermatitis	1.22e-05	0.000275	CcSEcCtD
Temsirolimus—Dermatitis—Triamcinolone—atopic dermatitis	1.22e-05	0.000275	CcSEcCtD
Temsirolimus—Rash—Methylprednisolone—atopic dermatitis	1.22e-05	0.000274	CcSEcCtD
Temsirolimus—Dermatitis—Methylprednisolone—atopic dermatitis	1.22e-05	0.000274	CcSEcCtD
Temsirolimus—Headache—Triamcinolone—atopic dermatitis	1.22e-05	0.000273	CcSEcCtD
Temsirolimus—Headache—Methylprednisolone—atopic dermatitis	1.21e-05	0.000273	CcSEcCtD
Temsirolimus—Body temperature increased—Prednisone—atopic dermatitis	1.21e-05	0.000272	CcSEcCtD
Temsirolimus—Abdominal pain—Prednisone—atopic dermatitis	1.21e-05	0.000272	CcSEcCtD
Temsirolimus—Diarrhoea—Betamethasone—atopic dermatitis	1.21e-05	0.000271	CcSEcCtD
Temsirolimus—Diarrhoea—Dexamethasone—atopic dermatitis	1.21e-05	0.000271	CcSEcCtD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	1.2e-05	0.00126	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL22—atopic dermatitis	1.18e-05	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	1.18e-05	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD79A—atopic dermatitis	1.18e-05	0.00124	CbGpPWpGaD
Temsirolimus—Dizziness—Betamethasone—atopic dermatitis	1.17e-05	0.000262	CcSEcCtD
Temsirolimus—Dizziness—Dexamethasone—atopic dermatitis	1.17e-05	0.000262	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	1.16e-05	0.00121	CbGpPWpGaD
Temsirolimus—Nausea—Triamcinolone—atopic dermatitis	1.15e-05	0.000259	CcSEcCtD
Temsirolimus—Nausea—Methylprednisolone—atopic dermatitis	1.15e-05	0.000259	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisone—atopic dermatitis	1.13e-05	0.000254	CcSEcCtD
Temsirolimus—Vomiting—Dexamethasone—atopic dermatitis	1.12e-05	0.000252	CcSEcCtD
Temsirolimus—Vomiting—Betamethasone—atopic dermatitis	1.12e-05	0.000252	CcSEcCtD
Temsirolimus—MTOR—Signaling by VEGF—IL6—atopic dermatitis	1.12e-05	0.00117	CbGpPWpGaD
Temsirolimus—Rash—Dexamethasone—atopic dermatitis	1.11e-05	0.00025	CcSEcCtD
Temsirolimus—Rash—Betamethasone—atopic dermatitis	1.11e-05	0.00025	CcSEcCtD
Temsirolimus—Dermatitis—Betamethasone—atopic dermatitis	1.11e-05	0.000249	CcSEcCtD
Temsirolimus—Dermatitis—Dexamethasone—atopic dermatitis	1.11e-05	0.000249	CcSEcCtD
Temsirolimus—MTOR—Immune System—STAT6—atopic dermatitis	1.11e-05	0.00116	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—atopic dermatitis	1.11e-05	0.00116	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	1.11e-05	0.00116	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR3—atopic dermatitis	1.11e-05	0.00116	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL2—atopic dermatitis	1.1e-05	0.00116	CbGpPWpGaD
Temsirolimus—Headache—Betamethasone—atopic dermatitis	1.1e-05	0.000248	CcSEcCtD
Temsirolimus—Headache—Dexamethasone—atopic dermatitis	1.1e-05	0.000248	CcSEcCtD
Temsirolimus—Asthenia—Prednisone—atopic dermatitis	1.1e-05	0.000247	CcSEcCtD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	1.09e-05	0.00115	CbGpPWpGaD
Temsirolimus—Pruritus—Prednisone—atopic dermatitis	1.09e-05	0.000244	CcSEcCtD
Temsirolimus—MTOR—Immune System—CARD11—atopic dermatitis	1.08e-05	0.00113	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL27—atopic dermatitis	1.05e-05	0.00111	CbGpPWpGaD
Temsirolimus—Diarrhoea—Prednisone—atopic dermatitis	1.05e-05	0.000236	CcSEcCtD
Temsirolimus—Nausea—Betamethasone—atopic dermatitis	1.05e-05	0.000235	CcSEcCtD
Temsirolimus—Nausea—Dexamethasone—atopic dermatitis	1.05e-05	0.000235	CcSEcCtD
Temsirolimus—MTOR—Cellular responses to stress—CXCL8—atopic dermatitis	1.02e-05	0.00107	CbGpPWpGaD
Temsirolimus—Dizziness—Prednisone—atopic dermatitis	1.01e-05	0.000228	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—NPS—atopic dermatitis	9.85e-06	0.00103	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TAC1—atopic dermatitis	9.85e-06	0.00103	CbGpPWpGaD
Temsirolimus—Vomiting—Prednisone—atopic dermatitis	9.76e-06	0.000219	CcSEcCtD
Temsirolimus—Rash—Prednisone—atopic dermatitis	9.67e-06	0.000217	CcSEcCtD
Temsirolimus—Dermatitis—Prednisone—atopic dermatitis	9.67e-06	0.000217	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—CXCR3—atopic dermatitis	9.66e-06	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SLC11A1—atopic dermatitis	9.63e-06	0.00101	CbGpPWpGaD
Temsirolimus—Headache—Prednisone—atopic dermatitis	9.61e-06	0.000216	CcSEcCtD
Temsirolimus—CYP3A7—Metabolism—GLB1—atopic dermatitis	9.5e-06	0.000997	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD8A—atopic dermatitis	9.5e-06	0.000997	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—atopic dermatitis	9.48e-06	0.000996	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL17—atopic dermatitis	9.46e-06	0.000993	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL5—atopic dermatitis	9.16e-06	0.000962	CbGpPWpGaD
Temsirolimus—Nausea—Prednisone—atopic dermatitis	9.11e-06	0.000205	CcSEcCtD
Temsirolimus—CYP3A7—Metabolism—ADSL—atopic dermatitis	9.11e-06	0.000956	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—atopic dermatitis	9.07e-06	0.000953	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—MAPK8—atopic dermatitis	8.99e-06	0.000944	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—atopic dermatitis	8.93e-06	0.000938	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CCR5—atopic dermatitis	8.65e-06	0.000908	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—atopic dermatitis	8.53e-06	0.000896	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—atopic dermatitis	8.49e-06	0.000891	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—atopic dermatitis	8.45e-06	0.000887	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—MAPK8—atopic dermatitis	8.43e-06	0.000886	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KIF3A—atopic dermatitis	8.43e-06	0.000885	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CASP1—atopic dermatitis	8.4e-06	0.000883	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—atopic dermatitis	8.4e-06	0.000882	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—atopic dermatitis	8.04e-06	0.000844	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	8e-06	0.00084	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL5—atopic dermatitis	7.97e-06	0.000837	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—atopic dermatitis	7.91e-06	0.00083	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	7.91e-06	0.00083	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—atopic dermatitis	7.91e-06	0.00083	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—atopic dermatitis	7.84e-06	0.000823	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL10—atopic dermatitis	7.81e-06	0.00082	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—atopic dermatitis	7.77e-06	0.000816	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—atopic dermatitis	7.73e-06	0.000812	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—NFKBIA—atopic dermatitis	7.67e-06	0.000805	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL11—atopic dermatitis	7.63e-06	0.000801	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CMA1—atopic dermatitis	7.63e-06	0.000801	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR2—atopic dermatitis	7.6e-06	0.000798	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	7.41e-06	0.000778	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—NFKBIA—atopic dermatitis	7.36e-06	0.000773	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	7.21e-06	0.000757	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STAT6—atopic dermatitis	7.17e-06	0.000753	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD79A—atopic dermatitis	7.15e-06	0.00075	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	7e-06	0.000735	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CASP8—atopic dermatitis	6.92e-06	0.000726	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GLB1—atopic dermatitis	6.87e-06	0.000721	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL5—atopic dermatitis	6.72e-06	0.000706	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ADSL—atopic dermatitis	6.58e-06	0.000691	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NGF—atopic dermatitis	6.23e-06	0.000654	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR3—atopic dermatitis	6.22e-06	0.000653	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR5—atopic dermatitis	6.06e-06	0.000636	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL18—atopic dermatitis	5.85e-06	0.000614	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD8A—atopic dermatitis	5.76e-06	0.000605	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—atopic dermatitis	5.74e-06	0.000603	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD4—atopic dermatitis	5.68e-06	0.000596	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NPS—atopic dermatitis	5.54e-06	0.000582	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TAC1—atopic dermatitis	5.54e-06	0.000582	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD4—atopic dermatitis	5.45e-06	0.000573	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCR3—atopic dermatitis	5.43e-06	0.000571	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD4—atopic dermatitis	5.43e-06	0.00057	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—atopic dermatitis	5.39e-06	0.000566	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GLB1—atopic dermatitis	5.18e-06	0.000544	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL5—atopic dermatitis	5.15e-06	0.000541	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NFKBIA—atopic dermatitis	5.13e-06	0.000539	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	5.02e-06	0.000527	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ADSL—atopic dermatitis	4.97e-06	0.000522	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GLB1—atopic dermatitis	4.88e-06	0.000513	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CCR5—atopic dermatitis	4.86e-06	0.000511	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MAPK8—atopic dermatitis	4.81e-06	0.000505	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ADSL—atopic dermatitis	4.68e-06	0.000492	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NFKBIA—atopic dermatitis	4.47e-06	0.000469	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL10—atopic dermatitis	4.39e-06	0.000461	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CASP8—atopic dermatitis	4.03e-06	0.000423	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.97e-06	0.000417	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL5—atopic dermatitis	3.78e-06	0.000397	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL8—atopic dermatitis	3.66e-06	0.000385	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.59e-06	0.000377	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NGF—atopic dermatitis	3.5e-06	0.000368	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2—atopic dermatitis	3.5e-06	0.000367	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—atopic dermatitis	3.43e-06	0.00036	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR5—atopic dermatitis	3.41e-06	0.000358	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD4—atopic dermatitis	3.31e-06	0.000347	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAPK8—atopic dermatitis	3.22e-06	0.000338	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.19e-06	0.000335	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARA—atopic dermatitis	3.08e-06	0.000324	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—atopic dermatitis	3.07e-06	0.000323	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.06e-06	0.000321	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—atopic dermatitis	3.06e-06	0.000321	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD4—atopic dermatitis	3.05e-06	0.000321	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2—atopic dermatitis	3.04e-06	0.00032	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—atopic dermatitis	2.94e-06	0.000308	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NFKBIA—atopic dermatitis	2.89e-06	0.000303	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MAPK8—atopic dermatitis	2.8e-06	0.000294	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARA—atopic dermatitis	2.23e-06	0.000234	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL8—atopic dermatitis	2.06e-06	0.000216	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—atopic dermatitis	2.06e-06	0.000216	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2—atopic dermatitis	1.97e-06	0.000207	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAPK8—atopic dermatitis	1.81e-06	0.00019	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—atopic dermatitis	1.79e-06	0.000188	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARA—atopic dermatitis	1.68e-06	0.000177	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—atopic dermatitis	1.65e-06	0.000173	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.58e-06	0.000166	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—atopic dermatitis	1.16e-06	0.000121	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.04e-06	0.000109	CbGpPWpGaD
